Key Events This Week
10 Aug: Downgrade to Strong Sell rating announced
11 Aug: Technical momentum shifts to bearish; stock closes at ₹402.70 (-0.30%)
13 Aug: Intraday recovery with 3.5% gain to ₹414.05
14 Aug: Mixed technical signals with daily moving averages turning mildly bullish

Panacea Biotec Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicator Signals
2026-08-14 08:03:05Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. Despite a recent upgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse before making decisions.
Read full news article
Panacea Biotec Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
2026-08-11 08:49:01Panacea Biotec Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 10 August 2026, driven primarily by deteriorating technical indicators, stagnant financial performance, and weak fundamental metrics. The pharmaceutical company’s Mojo Score has declined to 17.0, reflecting growing concerns over its valuation, financial trends, and market positioning amid a challenging sector environment.
Read full news article











